- Home
- INNV vs ETON Comparison
INNV vs ETON Comparison
Compare INNV & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INNV
- ETON
- Stock Information
- Founded
- INNV 2007
- ETON 2017
- Country
- INNV United States
- ETON United States
- Employees
- INNV N/A
- ETON N/A
- Industry
- INNV Medical/Nursing Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- INNV Health Care
- ETON Health Care
- Exchange
- INNV Nasdaq
- ETON Nasdaq
- Market Cap
- INNV 527.9M
- ETON 428.5M
- IPO Year
- INNV 2021
- ETON 2018
- Fundamental
- Price
- INNV $3.89
- ETON $13.57
- Analyst Decision
- INNV Sell
- ETON Strong Buy
- Analyst Count
- INNV 2
- ETON 3
- Target Price
- INNV $5.00
- ETON $29.67
- AVG Volume (30 Days)
- INNV 32.0K
- ETON 465.6K
- Earning Date
- INNV 05-06-2025
- ETON 08-07-2025
- Dividend Yield
- INNV N/A
- ETON N/A
- EPS Growth
- INNV N/A
- ETON N/A
- EPS
- INNV N/A
- ETON N/A
- Revenue
- INNV $831,683,000.00
- ETON $48,327,000.00
- Revenue This Year
- INNV $13.77
- ETON $103.21
- Revenue Next Year
- INNV $10.12
- ETON $51.34
- P/E Ratio
- INNV N/A
- ETON N/A
- Revenue Growth
- INNV 12.19
- ETON 40.88
- 52 Week Low
- INNV $2.60
- ETON $3.18
- 52 Week High
- INNV $6.69
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- INNV 54.58
- ETON 26.42
- Support Level
- INNV $3.62
- ETON $13.20
- Resistance Level
- INNV $4.03
- ETON $19.35
- Average True Range (ATR)
- INNV 0.19
- ETON 0.93
- MACD
- INNV -0.04
- ETON -0.49
- Stochastic Oscillator
- INNV 57.38
- ETON 6.02
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.